AB027. Long-acting beta-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids

BACKGROUND: Adding a long-acting β2-agonist (LABA) to inhaled corticosteroids (ICS) using a fixed-dose combination (FDC) inhaler containing ICS and LABA is the UK guideline-recommended step-up option for children aged >4 years with uncontrolled asthma on ICS monotherapy. The evidence of benefit o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Thorac Dis
Prif Awduron: Turner, Steve, Richardson, Kathryn, Murray, Clare, Thomas, Mike, Hillyer, Elizabeth V., Burden, Anne, Price, David B.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2016
Pynciau:
Session 3.2: Late Breaking Abstract Session
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4958741/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.s027
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg